Iran starts human testing of the first domestic COVID-19 vaccine

On Tuesday Iran launched human trials of its first domestic COVID-19 vaccine candidate which Tehran says could help it defeat the pandemic despite US sanctions interfering with its ability to import vaccines.

Setad, a giant state-affiliated conglomerate controlled by Iran’s supreme leader, said production of the vaccine developed by one of its companies, Shifa Pharmed, could reach 12 million doses per month, six months after a successful trial ends.